Evolution of Board Responsibility for Compliance Program Oversight

Description
This session will discuss the need for a company's Board of Directors to be actively engaged in the oversight of the development, implementation, and evaluation of the effectiveness of a company's Corporate Compliance Program. Guidance from the Officer of Inspector General and parallels between OIG expectations and Audit Committee requirements put in place by Sarbanes-Oxley will be discussed as we explore evolving expectations of the appropriate Compliance Program oversight role of their Board.

Objectives of the Presentation
Understand the following:
OIG Guidance for Boards of Directors on Compliance Oversight
Corporate Integrity Agreement requirements on Board Oversight Responsibilities
Parallels with Sarbanes Oxley Audit Committee Requirements
Board Reliance on Independent Compliance Expertise
Board Interactions with the Chief Compliance Officer
Impact of Shareholder Derivative Lawsuits

Why Should you Attend
It is essential that life sciences companies effectively manage the risks of commercializing a product in a highly regulated environment. Managing risk is the hallmark of an effective Corporate Compliance Program. Over the past several years, the Department of Justice and the Office of Inspector General have recovered billions of dollars from companies accused of violating the Food, Drug and Cosmetic Act, the Anti-Kickback Statute, and the False Claims Act. With its release last year of the Yates Memo, the DOJ upped the ante on the prosecution of individuals within companies. Prosecutions of individuals - including C-suite executives - for bad acts have increased and these acts can jeopardize a company's operations and its reputation. The Board of Directors must understand its role in the oversight the company's Corporate Compliance Program so that it can ensure that the company is taking appropriate steps to protect the company and its personnel.

Areas Covered
Overview of OIG Guidance for Boards Of Directors on Compliance Oversight
Highlighting CIA requirement
Demonstrating parallels with Sarbanes Oxley Audit Committee requirements
Discussing importance of independent compliance expertise
Exploring how the Board and the Chief Compliance Officer should interact
Exploring the role of shareholder suits in holding companies accountable

Who can Benefit
Members of healthcare company Boards of Directors
Outside counsel advising Boards of Directors
Chief Compliance Officers and their staff
Chief Risk Officers and their staff
General Counsel / healthcare compliance legal counsel
Senior management with Board reporting responsibilities
Enterprise risk management personnel

For Registration

http://onlinecompliancepanel.com/webinar/CORPORATE-COMPLIANCE-PROGRAM-501396/APRIL-2016-ES-WORLDCONCAL

Note: Use Promo code VBTPK and get 10% off on registration (Valid till May 31st 2016)